Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sugammadex dose-finding in Japanese subjects
NCT00591409Phase 2Completed
- Sponsor
- Merck & Co.
- Start
- Jan 2006
- Primary completion
- Sep 2006
- Modality
- Biodegradable Polymers, Small Molecules
01
Overview
A Phase 2 trial of Sugammadex in neuromuscular blockade (NMB), sponsored by Merck & Co.. Started Jan 2006; status: completed.
02
Drugs
Sugammadex
03
Conditions
neuromuscular blockade (NMB)
Beyond the preview
Go deeper on NCT00591409.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00591409.